The forecast for stomach malignant neoplasms mortality in the US shows a consistent value of 3.3 deaths per hundred thousand persons from 2024 to 2028. As of 2023, this figure remains stable at the reported level. With no year-on-year variation, the data suggests no change in mortality rates over this period. Looking at these years, the Compound Annual Growth Rate (CAGR) stands at 0%, indicating no expected growth or reduction in the mortality rate.
Future trends to watch for include advances in medical technology and treatment options, which could influence mortality rates. Additionally, changes in lifestyle factors and early detection programs could also impact future projections. Monitoring policy shifts in healthcare and public health initiatives will be essential in anticipating potential changes in these forecasts.
